Department of Pediatrics

Clinical Interests

My clinical interests include diagnosis and management of congenital anomalies of the kidney and urinary tract, chronic kidney disease, hypertension, kidney stones, urinary tract infections, glomerular diseases including nephrotic and nephritic syndromes, and electrolyte disorders. In the acute setting, as part of the dialysis and pheresis team, we provide all modalities of renal replacement therapies and therapeutic plasma exchange.

Education

• BS, Honors and High Distinction, The University of Iowa, 2001
• PhD, The University of Iowa, 2009
• MD, The University of Iowa Carver College of Medicine, 2009

Training

• Resident in Pediatrics, Saint Louis Children's Hospital, 2009 - 2011
• Fellow in Pediatric Nephrology, Washington University School of Medicine, 2011 - 2015

Licensure and Board Certification

• MO, State Board of Registration for the Healing Arts - Physician and Surgeon , 2012
• American Board of Pediatrics/General Pediatrics , 2012
• IL, Department of Financial and Professional Regulation - Licensed Physician and Surgeon , 2015
• The American Board of Pediatrics/Pediatric Nephrology , 2016

Honors

• Predoctoral Training Program in Genetics, National Institutes of Health, 5T32GM008629, PI: Jeffrey Murray, M.D., 2005 - 2007
• Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society, 2007
• Research Day Award for Best Graduate Student Basic Science Poster, Department of Internal Medicine, The University of Iowa Carver College of Medicine, 2007
• Research Week Poster Award, THe University of Iowa Carver College of Medicine, 2007
• Merck New Investigator Award, American Heart Association - Council on High Blood Pressure, 2007
• Best Poster Presentation Award, The University of Iowa Genetics Ph.D. Program, 2007
• Dean's Distinguished Dissertation Award, The University of Iowa, 2010
• Postdoctoral Developmental Cardiology and Pulmonary Training Program, National Institutes of Health, 5T32HL007873, PI: Robert Mecham, Ph.D., 2012 - 2014
• Trainee Research Award in Pediatric Nephrology, American Society of Pediatric Nephrology, 2014
• Physician Scientist Training Program, National Institutes of Health, 2T32HD043010, PI: Alan Schwartz, Ph.D., M.D., 2014 - 2015
• Pediatric Physician-Scientist Training Program Fellowship Support, Mallinckrodt Foundation, 2014 - 2015
• Travel Award, American Society for Matrix Biology, 2014
• "Teresa Vietti Fellow" Award, Department of Pediatrics, Washington University School of Medicine, 2015
• Scholar of the Child Health Research Center at Washington University School of Medicine, National Institutes of Health, K12-HD076224, 2015 - 2017

Recent Publications view all (15)

Publication Co-Authors

T. Keefe Davis, M.D.

Beth A. Kozel, M.D., Ph.D.

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Carmen Halabi, M.D., Ph.D.

1. Halabi CM, Mecham RP. Elastin purification and solubilization. Methods Cell Biol. 2018;143:207-222. PMID:29310779 
2. Halabi CM, Broekelmann TJ, Lin M, Lee VS, Chu ML, Mecham RP. Fibulin-4 is essential for maintaining arterial wall integrity in conduit but not muscular arteries. Sci Adv. 2017;3(5):e1602532. PMCID:PMC5415335  PMID:28508064 
3. McAlister AE, Geile K, Halabi CM, Davis TK. In tandem extracorporeal therapies during hemodialysis in pediatric patients. Hemodial Int. 2016;20 Suppl 1:S40-S43. PMID:27669548 
4. Lee VS, Halabi CM, Hoffman EP, Carmichael N, Leshchiner I, Lian CG, Bierhals AJ, Vuzman D, Brigham Genomic Medicine, Mecham RP, Frank NY, Stitziel NO. Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci U S A. 2016;113(31):8759-64. PMID:27432961 
5. Halabi CM, Broekelmann TJ, Knutsen RH, Ye L, Mecham RP, Kozel BA. Chronic antihypertensive treatment improves pulse pressure but not large artery mechanics in a mouse model of congenital vascular stiffness. Am J Physiol Heart Circ Physiol. 2015;309(5):H1008-16. doi:10.1152/ajpheart.00288.2015  PMID:26232234 
6. Igoucheva O, Alexeev V, Halabi CM, Adams SM, Stoilov I, Sasaki T, Arita M, Donahue A, Mecham RP, Birk DE, Chu ML. Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities. J Biol Chem. 2015;290(35):21443-59. doi:10.1074/jbc.M115.640425  PMID:26178373 
7. Davis TK, Halabi CM, Siefken P, Karmarkar S, Leonard J. Aggressive blood pressure control for chronic kidney disease unmasks moyamoya! Clin Kidney J. 2013;6(5):495-9. doi:10.1093/ckj/sft090  PMCID:PMC4438405  PMID:26064513 
8. Keen HL, Halabi CM, Beyer AM, de Lange WJ, Liu X, Maeda N, Faraci FM, Casavant TL, Sigmund CD. Bioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta. Arterioscler Thromb Vasc Biol. 2010;30(3):518-25. doi:10.1161/ATVBAHA.109.200733  PMCID:PMC2850258  PMID:20018933 
9. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res. 2010;106(2):373-82. doi:10.1161/CIRCRESAHA.109.208645  PMCID:PMC2818798  PMID:19926873 
10. de Lange WJ, Halabi CM, Beyer AM, Sigmund CD. Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed alleles. Physiol Genomics. 2008;35(1):1-4. doi:10.1152/physiolgenomics.90284.2008  PMCID:PMC2574738  PMID:18612081 
11. Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, Faraci FM, Sigmund CD. Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet. Circ Res. 2008;103(6):654-61. doi:10.1161/CIRCRESAHA.108.176339  PMCID:PMC2583077  PMID:18676352 
12. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD, Ghoneim SM, de Lange WJ, Keen HL, Tsai YS, Maeda N, Sigmund CD, Faraci FM. Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension. 2008;51(4):867-71. doi:10.1161/HYPERTENSIONAHA.107.103648  PMCID:PMC2408877  PMID:18285614 
13. Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, Sigmund CD. Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab. 2008;7(3):215-26. doi:10.1016/j.cmet.2007.12.008  PMCID:PMC2275166  PMID:18316027 
14. McCray PB Jr, Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, Netland J, Jia HP, Halabi C, Sigmund CD, Meyerholz DK, Kirby P, Look DC, Perlman S. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81(2):813-21. doi:10.1128/JVI.02012-06  PMCID:PMC1797474  PMID:17079315 
15. Halabi CM, Sigmund CD. Peroxisome proliferator-activated receptor-gamma and its agonists in hypertension and atherosclerosis : mechanisms and clinical implications. Am J Cardiovasc Drugs. 2005;5(6):389-98. PMID:16259527